(S)-16-((1-carboxy-5-(4-((2,5-dioxopyrrolidin-1-yl)oxy)-4-oxobutanamido)pentyl)amino)-16-oxohexadecanoic acid (abbreviated as L-HO-Pal-Lys(OSu)-OH) is a synthetic building block primarily used for lipidating peptides, proteins, or other molecules. It combines palmitic acid with lysine and succinic acid activated as an N-hydroxysuccinimide (NHS) ester (OSu). The long alkyl chain imparts lipophilicity, enabling membrane insertion, while the reactive NHS ester facilitates conjugation to primary amines. Applications include membrane-anchored peptide synthesis, liposomal drug delivery, and protein modification to enhance lipophilicity or membrane interaction.
Appearance
-
White to off-white solid, potentially waxy due to the palmitic acid chain.
Source
-
Synthetically produced via chemical synthesis.
-
Available from specialized chemical and bioconjugation reagent suppliers.
Molecular Weight and Structure
-
Molecular Weight: Approximately 695.9 g/mol (C36H61N3O10), depending on synthesis and purification.
-
Structure: Palmitic acid with a hydroxyl group at the omega carbon; lysine core; succinic acid linked to lysine’s epsilon-amino group as an active NHS ester.
Biological Activity
-
Biologically inert alone; activity depends on incorporation into larger molecules.
-
Long alkyl chain mediates membrane insertion, influencing localization and activity of conjugates.
-
NHS ester enables conjugation to biomolecules with primary amines.
Purity and Microbial Contamination
-
Purity: Typically ≥ 95% by HPLC analysis.
-
Microbial Contamination: Minimal or absent, with COAs verifying microbial quality.
-
Tested by bacterial endotoxin (LAL assay) and sterility assays.
Identity and Quality Control
-
Mass Spectrometry (MS) confirms molecular weight.
-
Nuclear Magnetic Resonance (NMR) (¹H and ¹³C) confirms chemical structure.
-
Infrared (IR) spectroscopy confirms characteristic functional groups.
-
HPLC to assess purity.
-
Amine quantification assays verify NHS ester presence and reactivity.
Shelf Life and Storage
| Feature | Description |
|---|---|
| Shelf Life | Typically 1–2 years if stored properly; refer to supplier’s Certificate of Analysis (CoA) |
| Storage | Store at -20°C or below, in inert atmosphere (argon or nitrogen), sealed and protected from moisture and light; avoid freeze-thaw cycles due to NHS ester sensitivity |
Application
-
Lipopeptide synthesis for membrane anchorage.
-
Protein lipidation to modulate membrane affinity.
-
Components of liposomal formulations for drug delivery enhancements.
-
Surface modification via hydrophobic coatings.
-
General bioconjugation reagent targeting primary amines.
Key Characteristics
-
Highly lipophilic palmitic acid chain for membrane interaction.
-
Reactive NHS ester for efficient conjugation chemistry.
-
Hydroxyl group offers additional functionalization options.
-
Soluble in organic solvents like chloroform, dichloromethane, and DMSO.
-
Versatile for synthetic conjugation applications.
Citation
-
NHS ester-mediated lipid conjugation of peptides and proteins:
https://pubmed.ncbi.nlm.nih.gov/30613757/ -
Lipid modification strategies for drug delivery applications:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653962/ -
Synthesis and biological applications of lipopeptides:
https://www.sciencedirect.com/science/article/pii/S0142961219304954 -
Use of N-hydroxysuccinimide esters in bioconjugation chemistry:
https://pubmed.ncbi.nlm.nih.gov/20420327/ -
Palmitoylation of proteins and its functional implications:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357263/ -
Liposomal drug delivery systems incorporating NHS ester lipids:
https://pubmed.ncbi.nlm.nih.gov/30817167/ -
Self-assembling peptides with lipid modifications for biomedical use:
https://pubmed.ncbi.nlm.nih.gov/29395641/ -
NHS ester reagents in site-specific protein modification:
https://pubmed.ncbi.nlm.nih.gov/29454358/ -
Chemical databases for palmitoyl-lysine derivatives and synthetic protocols:
https://www.chemspider.com/Chemical-Structure.16756308.html -
Patents on lipid-protein conjugation and lipopeptide therapeutics:
https://patents.google.com/patent/US20170268536A1/en
![(S)-16-((1-carboxy-5-(4-((2,5-dioxopyrrolidin-1-yl)oxy)-4-oxobutanamido)pentyl)amino)-16-oxohexadecanoic acid [L-HO-Pal-Lys(OSu)-OH]](https://novacellbio.com/wp-content/uploads/2025/08/S-16-1-carboxy-5-4-25-dioxopyrrolidin-1-yloxy-4-oxobutanamidopentylamino-16-oxohexadecanoic-acid-L-HO-Pal-LysOSu-OH.png)
Reviews
There are no reviews yet.